Skip to content

Acupressure and Hypnosis in Hypertension - a Series of n-of-1 RCTs with a Mixed-Methods Design

Acupressure and Hypnosis in Hypertension - a Series of n-of-1 RCTs with a Mixed-Methods Design - ACUHyp

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034937
Enrollment
15
Registered
2024-08-28
Start date
2024-10-21
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I10.01

Interventions

Group 1: The explorative N-of-1 studies consist of 2 three-week cycles, each consisting of five days of acupressure, five days of hypnosis and seven days of routine care, each in randomized order. The

Sponsors

Institut für Sozialmedizin, Epidemiologie und Gsundheitsökonomie, Charité Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Previously diagnosed essential hypertension up to grade 2 (RR values systolic/diastolic: 140-179/90-109 mmHg) - Ability to consent and signed informed consent form - Arm circumference between 22 cm and 32 cm - Possession of an e-mail address and internet access

Exclusion criteria

Exclusion criteria: Antihypertensive medication with more than two active substances - Known secondary hypertension (e.g. due to renal artery stenosis, medication) - Known other manifest cardiovascular diseases (e.g. PAD, CHD) - Known higher-grade cardiac arrhythmia (occasional ventricular and supraventricular extrasystoles are not included) - Known pregnancy - Lack of or insufficient knowledge of the German language - Known and manifest mental and/or psychiatric illness - Known cognitive impairments (including memory disorders) - Known illnesses of the hands or fingers that make acupressure impossible - Known concomitant chronic pain disorders - Known visual and/or hearing impairment that cannot be compensated for by aids (e.g. glasses or hearing aid) - Participation in another study

Design outcomes

Primary

MeasureTime frame
systolic and diastolic blood pressure

Secondary

MeasureTime frame
heart frequency, VAS perceived stress, VAS perceived well-being, VAS perceived vitality

Countries

Germany

Contacts

Public ContactMiriam Ortiz

Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité Universitätsmedizin Berlin

miriam.ortiz@charite.de+49 30 450 529 069

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 19, 2026